{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:30:26Z","timestamp":1791275426676,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Aldosterone, which plays a key role in maintaining water and electrolyte balance, is produced by zona glomerulosa cells of the adrenal cortex. Autonomous overproduction of aldosterone from zona glomerulosa cells causes primary hyperaldosteronism. Recent clinical studies have highlighted the pathological role of the KCNJ5 potassium channel in primary hyperaldosteronism. Our objective was to determine whether small-conductance Ca<jats:sup>2+<\/jats:sup>-activated potassium (SK) channels may also regulate aldosterone secretion in human adrenocortical cells. We found that apamin, the prototypic inhibitor of SK channels, decreased membrane voltage, raised intracellular Ca<jats:sup>2+<\/jats:sup>and dose dependently increased aldosterone secretion from human adrenocortical H295R cells. By contrast, 1-Ethyl-2-benzimidazolinone, an agonist of SK channels, antagonized apamin\u2019s action and decreased aldosterone secretion. Commensurate with an increase in aldosterone production, apamin increased mRNA expression of steroidogenic acute regulatory protein and aldosterone synthase that control the early and late rate-limiting steps in aldosterone biosynthesis, respectively. In addition, apamin increased angiotensin II\u2013stimulated aldosterone secretion, whereas 1-Ethyl-2-benzimidazolinone suppressed both angiotensin II\u2013 and high K<jats:sup>+<\/jats:sup>\u2013stimulated production of aldosterone in H295R cells. These findings were supported by apamin-modulation of basal and angiotensin II\u2013stimulated aldosterone secretion from acutely prepared slices of human adrenals. We conclude that SK channel activity negatively regulates aldosterone secretion in human adrenocortical cells. Genetic association studies are necessary to determine whether mutations in SK channel subtype 2 genes may also drive aldosterone excess in primary hyperaldosteronism.<\/jats:p>","DOI":"10.1161\/hypertensionaha.116.07094","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T03:09:26Z","timestamp":1468897766000},"page":"785-795","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Small-Conductance Ca<sup>2+<\/sup>-Activated Potassium Channels Negatively Regulate Aldosterone Secretion in Human Adrenocortical Cells"],"prefix":"10.1161","volume":"68","author":[{"given":"Tingting","family":"Yang","sequence":"first","affiliation":[{"name":"From the Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science (T.Y., Q.L., Y.-A.M., C.H.) and Department of Oncology, Shanghai Medical College (H.-L.Z.), Fudan University, China; Department of Urology, Fudan University Shanghai Cancer Center, China (H.-L.Z.); and Department of Pharmacology, University of Virginia, Charlottesville (Y.S., P.Q.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Liang","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science (T.Y., Q.L., Y.-A.M., C.H.) and Department of Oncology, Shanghai Medical College (H.-L.Z.), Fudan University, China; Department of Urology, Fudan University Shanghai Cancer Center, China (H.-L.Z.); and Department of Pharmacology, University of Virginia, Charlottesville (Y.S., P.Q.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingnan","family":"Liang","sequence":"additional","affiliation":[{"name":"From the Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science (T.Y., Q.L., Y.-A.M., C.H.) and Department of Oncology, Shanghai Medical College (H.-L.Z.), Fudan University, China; Department of Urology, Fudan University Shanghai Cancer Center, China (H.-L.Z.); and Department of Pharmacology, University of Virginia, Charlottesville (Y.S., P.Q.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingtang","family":"Shi","sequence":"additional","affiliation":[{"name":"From the Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science (T.Y., Q.L., Y.-A.M., C.H.) and Department of Oncology, Shanghai Medical College (H.-L.Z.), Fudan University, China; Department of Urology, Fudan University Shanghai Cancer Center, China (H.-L.Z.); and Department of Pharmacology, University of Virginia, Charlottesville (Y.S., P.Q.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ai","family":"Mei","sequence":"additional","affiliation":[{"name":"From the Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science (T.Y., Q.L., Y.-A.M., C.H.) and Department of Oncology, Shanghai Medical College (H.-L.Z.), Fudan University, China; Department of Urology, Fudan University Shanghai Cancer Center, China (H.-L.Z.); and Department of Pharmacology, University of Virginia, Charlottesville (Y.S., P.Q.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Q.","family":"Barrett","sequence":"additional","affiliation":[{"name":"From the Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science (T.Y., Q.L., Y.-A.M., C.H.) and Department of Oncology, Shanghai Medical College (H.-L.Z.), Fudan University, China; Department of Urology, Fudan University Shanghai Cancer Center, China (H.-L.Z.); and Department of Pharmacology, University of Virginia, Charlottesville (Y.S., P.Q.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlong","family":"Hu","sequence":"additional","affiliation":[{"name":"From the Department of Physiology and Biophysics, School of Life Sciences, Institutes of Brain Science (T.Y., Q.L., Y.-A.M., C.H.) and Department of Oncology, Shanghai Medical College (H.-L.Z.), Fudan University, China; Department of Urology, Fudan University Shanghai Cancer Center, China (H.-L.Z.); and Department of Pharmacology, University of Virginia, Charlottesville (Y.S., P.Q.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-118-1-112"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)47233-4"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-107-5-1345"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-118-2-869"},{"issue":"5","key":"e_1_3_3_6_2","first-page":"E645","article-title":"Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion.","volume":"247","author":"Kojima K","year":"1984","unstructured":"Kojima K, Kojima I, Rasmussen H. Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion. Am J Physiol. 1984;247(5 pt 1):E645\u2013E650.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2003"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.76"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02775.x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0104"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.197111"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01060"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.183996"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1927"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2965"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1733"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.4.9"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-020911-153336"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12250"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.16.8957-8951.2003"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(24)39107-4","article-title":"Comparison of L-type calcium channel blockade by nifedipine and\/or cadmium in guinea pig ventricular myocytes.","volume":"294","author":"Shen JB","year":"2000","unstructured":"Shen JB, Jiang B, Pappano AJ. Comparison of L-type calcium channel blockade by nifedipine and\/or cadmium in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 2000;294:562\u2013570.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.073205"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2006.04.020"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1752"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004240000447"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00028-4"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.2.409"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703120"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703111"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-002-0622-2"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-09-03404.2002"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-19-07307.1997"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1995.268.4.C985"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.11.8895352"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0022-3565(24)37868-1","article-title":"Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.","volume":"287","author":"Rossier MF","year":"1998","unstructured":"Rossier MF, Ertel EA, Vallotton MB, Capponi AM. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells. J Pharmacol Exp Ther. 1998;287:824\u2013831.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(01)00384-7"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1339"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61996"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.141233398"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000156448.74296.FE"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344088"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874467208666150507105443"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-004-0934-5"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1921"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1915"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.116.07094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T02:05:13Z","timestamp":1749002713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.116.07094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.116.07094"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.116.07094","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"2016-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}